The Oncology Institute, Inc. (TOI) Stock Analysis — Probabli.AI
AI-powered analysis for TOI (The Oncology Institute, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $3.59 · Market cap: $335.5M · AI outlook: Bullish
The Oncology Institute, Inc. (TOI) demonstrates strong potential for significant market outperformance due to strategic partnerships, high revenue growth expectations, and expanding telehealth and R&D capabilities. While challenges including operational cost issues and regulatory delays persist, the positive forecasted drivers far outweigh potential setbacks. Given the analyst consensus and a…
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 30% · Bear 10%
- 1-year price estimates — P10: $2 / P50: $6 / P90: $8
- The strong analyst consensus with a mean price target nearly double its current price suggests high upside potential. Positive headlines indicate operational growth and strategic expansions, supporting a bullish stance.…
5-Year Outlook
- Bull 70% · Neutral 20% · Bear 10%
- 5-year price estimates — P10: $4 / P50: $15 / P90: $25
SWOT Highlights
- Strength: High revenue growth projection.
- Strength: Strong strategic partnerships.
- Risk: High operational costs.
- Risk: Negative earnings surprises.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
3 Wall Street analysts rate TOI a STRONG BUY with a mean price target of $6.67.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
TOI forecast details · TOI sentiment details
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.